EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Benefits And Risks of Vildagliptin/Metformin Versus Sulphonylureas/Metformin Combination Therapy In Type 2 Diabetes Mellitus (T2dm) From Patient's Perspective: Real-World Data






Value in Health 18(7): A615-A615

Benefits And Risks of Vildagliptin/Metformin Versus Sulphonylureas/Metformin Combination Therapy In Type 2 Diabetes Mellitus (T2dm) From Patient's Perspective: Real-World Data



Accession: 057291184

PMID: 26533451

DOI: 10.1016/j.jval.2015.09.2140



Related references

Ji, L-Nong.; Pan, C-Yu.; Lu, J-Ming.; Li, H.; Li, Q.; Li, Q-Fu.; Peng, Y-De.; Tian, H-Ming.; Yao, C.; Zhao, Z-Gang.; Zhang, R-Ya.; Wang, X-Ling.; Wang, L., 2014: Efficacy and safety of combination therapy with vildagliptin and metformin versus metformin up-titration in Chinese patients with type 2 diabetes mellitus: study design and rationale of the vision study. Limitations of the currently recommended stepwise treatment pathway for type 2 diabetes mellitus (T2DM), especially the failure of monotherapies to maintain good glycemic control, have prompted use of early, more aggressive combination therapies.T...

Ji, L-N.; Pan, C-Y.; Lu, J-M.; Li, H.; Zhu, D-L.; Li, Q.; Li, Q-F.; Peng, Y-D.; Tian, H-M.; Yao, C.; Zhao, Z-G.; Wang, L.; Wang, B-H., 2016: Efficacy and safety of combination therapy with vildagliptin and metformin versus metformin uptitration in Chinese patients with type 2 diabetes inadequately controlled with metformin monotherapy: a randomized, open-label, prospective study (VISION). To compare the efficacy and safety of combination of vildagliptin and metformin therapy with metformin uptitration in Chinese patients with type 2 diabetes (T2DM) inadequately controlled with low-dose metformin. In this 24-week prospective, random...

Krysanov, I.; Tiapkina, M., 2015: Economic Evaluation of Saxagliptin in Combination with Metformin Versus Sitagliptin or Vildagliptin in Combination with Metformin in Patients with Type 2 Diabetes in Russia. Value in Health 18(7): A608-A608

Viriato, D.; Calado, F.; Gruenberger, J-Bernard.; Ong, S.Hwa.; Carvalho, D.; Silva-Nunes, Jé.; Johal, S.; Viana, R., 2015: Cost-effectiveness of metformin plus vildagliptin compared with metformin plus sulphonylurea for the treatment of patients with type 2 diabetes mellitus: a Portuguese healthcare system perspective. To evaluate the cost-effectiveness of vildagliptin plus metformin vs generic sulphonylurea plus metformin in patients with type 2 diabetes mellitus, not controlled with metformin, from a Portuguese healthcare system perspective. A cost-effectivene...

Guarino, E.; Nigi, L.; Patti, A.; Fondelli, C.; Dotta, F., 2012: Combination therapy with metformin plus vildagliptin in type 2 diabetes mellitus. Type 2 diabetes mellitus (T2DM) is pathophysiologically characterized by a combination of insulin resistance and beta-cell dysfunction. Consequently, a proper treatment of such a disease should target both of these defects. Dipeptidyl peptidase-4...

Rombopoulos, G.; Hatzikou, M.; Athanasiadis, A.; Elisaf, M., 2015: Treatment Compliance with Fixed-Dose Combination of Vildagliptin/Metformin in Patients with Type 2 Diabetes Mellitus Inadequately Controlled with Metformin Monotherapy: A 24-Week Observational Study. Objective. To evaluate the differences in treatment compliance with vildagliptin/metformin fixed-dose versus free-dose combination therapy in patients with type 2 diabetes mellitus (T2DM) in Greece. Design. Adult patients with T2DM, inadequately c...

Derosa, G.; Gaddi, A.V.; Piccinni, M.N.; Ciccarelli, L.; Salvadeo, S.; Peros, E.; Ghelfi, M.; Ferrari, I.; Cicero, A.F.G., 2005: Antithrombotic effects of rosiglitazone-metformin versus glimepiride-metformin combination therapy in patients with type 2 diabetes mellitus and metabolic syndrome. Study Objective. To evaluate the differential effect on coagulation and fibrinolysis parameters of combination therapy with glimepiride-metformin and with rosiglitazone-metformin beyond their effect on glucose metabolism in patients with type 2 di...

Su, Y.; Su, Y-Li.; Lv, L-Fang.; Wang, L-Min.; Li, Q-Zhong.; Zhao, Z-Gang., 2014: A randomized controlled clinical trial of vildagliptin plus metformin combination therapy in patients with type II diabetes mellitus. The aim of the present study was to assess the efficacy and safety of vildagliptin plus metformin combination therapy in patients with type II diabetes mellitus. Type II diabetic patients with poor glycemic control following at least three months...

Lundby-Christensen, L.; Tarnow, L.; Boesgaard, T.W.; Lund, Søren.S.; Wiinberg, N.; Perrild, H.; Krarup, T.; Snorgaard, O.; Gade-Rasmussen, B.; Thorsteinsson, B.; Røder, M.; Mathiesen, E.R.; Jensen, T.; Vestergaard, H.; Hedetoft, C.; Breum, L.; Duun, E.; Sneppen, S.B.; Pedersen, O.; Hemmingsen, B.; Carstensen, B.; Madsbad, S.; Gluud, C.; Wetterslev, Jørn.; Vaag, A.; Almdal, T.P., 2016: Metformin versus placebo in combination with insulin analogues in patients with type 2 diabetes mellitus-the randomised, blinded Copenhagen Insulin and Metformin Therapy (CIMT) trial. To assess the effect of metformin versus placebo both in combination with insulin analogue treatment on changes in carotid intima-media thickness (IMT) in patients with type 2 diabetes. Investigator-initiated, randomised, placebo-controlled trial...

González-Ortiz, M.; Guerrero-Romero, Jús.F.; Violante-Ortiz, R.; Wacher-Rodarte, N.; Martínez-Abundis, E.; Aguilar-Salinas, C.; Islas-Andrade, S.; Arechavaleta-Granell, R.; González-Canudas, J.; Rodríguez-Morán, M.; Zavala-Suárez, E.; Ramos-Zavala, M.G.; Metha, R.; Revilla-Monsalve, C.; Beltrán-Jaramillo, T.J., 2008: Efficacy of glimepiride/metformin combination versus glibenclamide/metformin in patients with uncontrolled type 2 diabetes mellitus. The aim of this study was to compare the efficacy of glimepiride/metformin combination versus glibenclamide/metformin for reaching glycemic control in patients with uncontrolled type 2 diabetes mellitus. A randomized, double-blind, multicenter cli...